Cargando…
The Role of Serum Adiponectin for Outcome Prediction in Patients with Dilated Cardiomyopathy and Advanced Heart Failure
Clinical interpretation of patients' plasma adiponectin (APN) remains challenging; its value as biomarker in dilated cardiomyopathy (DCM) is equivocal. We evaluated whether circulating APN level is an independent predictor of composite outcome: death, left ventricle assist device (LVAD) implant...
Autores principales: | Baltrūnienė, Vaida, Bironaitė, Daiva, Kažukauskienė, Ieva, Bogomolovas, Julius, Vitkus, Dalius, Ručinskas, Kęstutis, Žurauskas, Edvardas, Augulis, Renaldas, Grabauskienė, Virginija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727561/ https://www.ncbi.nlm.nih.gov/pubmed/29318144 http://dx.doi.org/10.1155/2017/3818292 |
Ejemplares similares
-
Inflammation-Related Biomarkers Are Associated with Heart Failure Severity and Poor Clinical Outcomes in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Kažukauskienė, Ieva, et al.
Publicado: (2021) -
The Role of Cardiac T-Cadherin in the Indicating Heart Failure Severity of Patients with Non-Ischemic Dilated Cardiomyopathy
por: Baltrūnienė, Vaida, et al.
Publicado: (2020) -
Molecular mechanisms behind progressing chronic inflammatory dilated cardiomyopathy
por: Bironaite, Daiva, et al.
Publicado: (2015) -
Prevalence and prognostic relevance of myocardial inflammation and cardiotropic viruses in non-ischemic dilated cardiomyopathy
por: Kažukauskienė, Ieva, et al.
Publicado: (2022) -
Left ventricular global longitudinal strain predicts elevated cardiac pressures and poor clinical outcomes in patients with non-ischemic dilated cardiomyopathy
por: Kažukauskienė, Ieva, et al.
Publicado: (2021)